Literature DB >> 15164150

Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease.

G Beyens1, E Van Hul, K Van Driessche, E Fransen, J-P Devogelaer, F Vanhoenacker, J Van Offel, L Verbruggen, L De Clerck, R Westhovens, W Van Hul.   

Abstract

A positional cloning effort in French Canadian families with Paget's disease of bone (PDB) resulted in the identification of a mutation in the sequestosome1 (SQSTM1) gene in a subset of both familial and sporadic PDB cases. This was confirmed in samples of mainly United Kingdom (UK) origin. In this study, we performed both mutation analysis and association studies in order to evaluate the role of this gene in a collection of isolated Belgian PDB patients. A mutation in the SQSTM1 gene was found in only 6 of 111 patients (5.4%). In all cases it involves the P392L mutation, previously shown to be common in both familial and sporadic cases. To perform association studies, we selected 8 single nucleotide polymorphisms (SNPs) and looked for linkage disequilibrium (LD) between these. Haplotype analysis indicated that typing of 3 Tag SNPs (IVS1 + 633A/C, IVS5 - 23A/G, and 976A/G) enables us to identify the most common haplotypes. Association studies for the 3 selected SNPs, based on 105 PDB cases without a SQSTM1 mutation and 159 control individuals, did not support a possible influence of natural variants in the SQSTM1 gene either on the pathogenesis of PDB or on the disease severity. In conclusion, our study confirms that the P392L mutation is a recurrent mutation causing PDB in different populations. We were not able to show an association between SQSTM1 polymorphisms and PDB in our population but this clearly needs to be extended to other populations. The presented identification of haplotype Tag SNPs will be of major help for such studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164150     DOI: 10.1007/s00223-004-0244-4

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  11 in total

Review 1.  Cellular and molecular biology of optineurin.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.

Authors:  Pui Yan Jenny Chung; Greet Beyens; Steven Boonen; Socrates Papapoulos; Piet Geusens; Marcel Karperien; Filip Vanhoenacker; Leon Verbruggen; Erik Fransen; Jan Van Offel; Stefan Goemaere; Hans-Georg Zmierczak; René Westhovens; Jean-Pierre Devogelaer; Wim Van Hul
Journal:  Hum Genet       Date:  2010-09-14       Impact factor: 4.132

3.  Paget's disease: epidemiology and pathophysiology.

Authors:  Margaret Seton
Journal:  Curr Osteoporos Rep       Date:  2008-12       Impact factor: 5.096

Review 4.  Emerging strategies and therapies for treatment of Paget's disease of bone.

Authors:  Laëtitia Michou; Jacques P Brown
Journal:  Drug Des Devel Ther       Date:  2011-04-26       Impact factor: 4.162

Review 5.  Paget's disease of bone-genetic and environmental factors.

Authors:  Frederick R Singer
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

6.  Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget's disease of bone.

Authors:  Anand Merchant; Magda Smielewska; Nimit Patel; Jennifer D Akunowicz; Elizabeth A Saria; John D Delaney; Robin J Leach; Margaret Seton; Marc F Hansen
Journal:  J Bone Miner Res       Date:  2009-03       Impact factor: 6.741

7.  TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations.

Authors:  YouJin Lee; Per Harald Jonson; Jaakko Sarparanta; Johanna Palmio; Mohona Sarkar; Anna Vihola; Anni Evilä; Tiina Suominen; Sini Penttilä; Marco Savarese; Mridul Johari; Marie-Christine Minot; David Hilton-Jones; Paul Maddison; Patrick Chinnery; Jens Reimann; Cornelia Kornblum; Torsten Kraya; Stephan Zierz; Carolyn Sue; Hans Goebel; Asim Azfer; Stuart H Ralston; Peter Hackman; Robert C Bucelli; J Paul Taylor; Conrad C Weihl; Bjarne Udd
Journal:  J Clin Invest       Date:  2018-02-19       Impact factor: 14.808

Review 8.  Clinical and Genetic Advances in Paget's Disease of Bone: a Review.

Authors:  N Alonso; I Calero-Paniagua; J Del Pino-Montes
Journal:  Clin Rev Bone Miner Metab       Date:  2016-12-19

Review 9.  Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline.

Authors:  Stuart H Ralston; Luis Corral-Gudino; Cyrus Cooper; Roger M Francis; William D Fraser; Luigi Gennari; Núria Guañabens; M Kassim Javaid; Robert Layfield; Terence W O'Neill; R Graham G Russell; Michael D Stone; Keith Simpson; Diana Wilkinson; Ruth Wills; M Carola Zillikens; Stephen P Tuck
Journal:  J Bone Miner Res       Date:  2019-02-25       Impact factor: 6.741

Review 10.  Genetic Determinants of Paget's Disease of Bone.

Authors:  Navnit S Makaram; Stuart H Ralston
Journal:  Curr Osteoporos Rep       Date:  2021-05-14       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.